Our data also suggest that brain IDO1 activity is an important regulator of depression-like behavior following ICV LPS, since genetic deletion or pharmacological inhibition of brain IDO1 protected mice from LPS-induced depression-like behavior. The gene discussed is IDO1; the disease is depressive symptom measurement.